J. Sung

发表

The role of lamivudine and predictors of mortality in severe flare‐up of chronic hepatitis B with jaundice

H. Chan, S. Tsang, Y. Hui, 2002, Journal of viral hepatitis.

Expression of cyclooxygenase‐2 in chronic hepatitis B and the effects of anti‐viral therapy

N. Leung, J. Sung, K. To, 2002, Alimentary pharmacology & therapeutics.

Randomized trial of low‐dose misoprostol and naproxen vs. nabumetone to prevent recurrent upper gastrointestinal haemorrhage in users of non‐steroidal anti‐inflammatory drugs

Y. Hui, F. Chan, J. Sung, 2001, Alimentary pharmacology & therapeutics.

CXCL10 plays a key role as an inflammatory mediator and a non-invasive biomarker of non-alcoholic steatohepatitis.

Jun Yu, T. Yau, V. Wong, 2014, Journal of hepatology.

Metabolic and histological features of non‐alcoholic fatty liver disease patients with different serum alanine aminotransferase levels

S. Tsang, F. Chan, J. Sung, 2009, Alimentary pharmacology & therapeutics.

Systematic review: the efficacy of herbal therapy in inflammatory bowel disease

Justin C.Y. Wu, K. Tsoi, F. Chan, 2013, Alimentary pharmacology & therapeutics.

Clinical and histological features of non‐alcoholic fatty liver disease in Hong Kong Chinese

F. Chan, J. Sung, F. Chan, 2004, Alimentary pharmacology & therapeutics.

Randomised clinical trial: efficacy of peginterferon alfa‐2a in HBeAg positive chronic hepatitis B patients with lamivudine resistance

J. Sung, J. Sung, J. Sheng, 2011, Alimentary pharmacology & therapeutics.

Expression and cellular localization of COX‐1 and ‐2 in Helicobacter pylori gastritis

F. Chan, J. Sung, W. Leung, 2001, Alimentary pharmacology & therapeutics.

Up‐regulation of cyclooxygenase‐1 and ‐2 in human gastric ulcer

J. Sung, Y. Ng, T. L. Lee, 2001, Alimentary pharmacology & therapeutics.

Dyspepsia is strongly associated with major depression and generalised anxiety disorder ‐ a community study

F. Chan, J. Sung, Y. Chan, 2012, Alimentary pharmacology & therapeutics.

Early virological suppression is associated with good maintained response to adefovir dipivoxil in lamivudine resistant chronic hepatitis B

J. Sung, G. Wong, A. Chim, 2007, Alimentary pharmacology & therapeutics.

The efficacy of thymosin in the treatment of chronic hepatitis B virus infection: a meta‐analysis

J. Sung, H. Chan, W. Tam, 2001, Alimentary pharmacology & therapeutics.

Shorter durations and lower doses of peginterferon alfa‐2a are associated with inferior hepatitis B e antigen seroconversion rates in hepatitis B virus genotypes B or C

P. Marcellin, Y. Liaw, J. Sung, 2011, Hepatology.

Peroxisome proliferator‐activated receptor‐gamma Pro12Ala polymorphism, Helicobacter pylori infection and non‐cardia gastric carcinoma in Chinese

J. Sung, B. Chen, P. Hu, 2006, Alimentary pharmacology & therapeutics.

Systematic review with meta‐analysis: review of donor features, procedures and outcomes in 168 clinical studies of faecal microbiota transplantation

S. Wong, S. Ng, F. Chan, 2019, Alimentary pharmacology & therapeutics.

Prevalence of undiagnosed diabetes and postchallenge hyperglycaemia in Chinese patients with non‐alcoholic fatty liver disease

F. Chan, J. Sung, W. So, 2006, Alimentary pharmacology & therapeutics.

Helicobacter species and hepatobiliary diseases

J. Sung, J. Sung, R. Leong, 2002 .

Predictors of corticosteroid‐dependent and corticosteroid‐refractory inflammatory bowel disease: analysis of a Chinese cohort study

V. Wong, F. Chan, J. Sung, 2009, Alimentary pharmacology & therapeutics.

Review article: the role of non‐biological drugs in refractory inflammatory bowel disease

S. Ng, F. Chan, J. Sung, 2011, Alimentary pharmacology & therapeutics.

Effect of Helicobacter pylori eradication on oesophageal acid exposure in patients with reflux oesophagitis

Justin C.Y. Wu, F. Chan, J. Sung, 2002, Alimentary pharmacology & therapeutics.

Imaging in Severe Acute Respiratory Syndrome (SARS)

J. Sung, D. Hui, F. Cheng, 2003, Clinical Radiology.

Economic analysis of four triple regimens for the treatment of Helicobacter pylori‐related peptic ulcer disease in in‐patient and out‐patient settings in Hong Kong

J. You, J. Sung, G. Yee, 2001, Alimentary pharmacology & therapeutics.

Economic analysis of celecoxib versus diclofenac plus omeprazole for the treatment of arthritis in patients at risk of ulcer disease

V. Lee, J. You, F. Chan, 2003, Alimentary pharmacology & therapeutics.

Development and validation of a disease‐specific quality of life questionnaire for gastro‐oesophageal reflux disease: the GERD‐QOL questionnaire

F. Chan, J. Sung, Y. Chan, 2010, Alimentary pharmacology & therapeutics.

Association between serrated polyps and the risk of synchronous advanced colorectal neoplasia in average‐risk individuals

F. Chan, J. Sung, J. Ching, 2015, Alimentary pharmacology & therapeutics.

Dysfunction of oesophageal motility in Helicobacter pylori‐infected patients with reflux oesophagitis

F. Chan, J. Sung, W. Leung, 2001, Alimentary pharmacology & therapeutics.

Concomitant irritable bowel syndrome is associated with failure of step‐down on‐demand proton pump inhibitor treatment in patients with gastro‐esophageal reflux disease

Justin C.Y. Wu, F. Chan, F. Chan, 2011, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Double‐blinded placebo‐controlled study of Phyllanthus urinaris for the treatment of chronic hepatitis B

J. Sung, K. Fung, P. Leung, 2003, Alimentary pharmacology & therapeutics.

Agreements among traditional Chinese medicine practitioners in the diagnosis and treatment of irritable bowel syndrome

F. Chan, J. Sung, B. Berman, 2004, Alimentary pharmacology & therapeutics.

Diagnosis of Gastroesophageal Varices and Portal Collateral Venous Abnormalities by Endosonography in Cirrhotic Patients

F. Chan, J. Sung, F. Chan, 2002, Endoscopy.

Should we eradicate Helicobacter pylori in non‐steroidal anti‐inflammatory drug users?

J. Sung, 2004, Alimentary pharmacology & therapeutics.

Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B

V. Wong, F. Chan, J. Sung, 2008, Gut.

Metabolic and histological features of non‐alcoholic fatty liver disease patients with different serum alanine aminotransferase levels

S. Tsang, F. Chan, J. Sung, 2009, Alimentary pharmacology & therapeutics.

Commentary: psychological disorders linked to functional dyspepsia – authors' reply

F. Chan, J. Sung, Y. Chan, 2012 .

Somatic beta-catenin mutation in gastric carcinoma--an infrequent event that is not specific for microsatellite instability.

F. Chan, J. Sung, W. Leung, 2001, Cancer letters.